If You Invested in CIPHER PHARMS INC (CPHRF)
Looking for the current price? See the CPHRF quote & overviewWhat $1,000 or $10,000 in CPHRF Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Dec 31, 2021 |
|---|---|---|---|---|
| $1,000 | $934 -7% | — | — | $6,816 +582% |
| $10,000 | $9,339 -7% | — | — | $68,156 +582% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-10-28. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CPHRF$1,000 Investment Over Time
CPHRF vs S&P 500Year-by-Year Returns
CPHRF annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2022 | $1.41 | $2.79 | +98.2% | +98.2% |
| 2023 | $2.79 | $4.19 | +49.9% | +197.2% |
| 2024 | $4.19 | $9.97 | +137.9% | +606.8% |
| 2025 | $9.97 | $10.98 | +10.2% | +678.7% |
| 2026 | $10.98 | $9.61 | -12.5% | +581.6% |
About CIPHER PHARMS INC
Healthcare · OTC
Similar Stocks
See how related companies performed
Frequently Asked Questions
CIPHER PHARMS INC investment returns
How much would $1,000 invested in CIPHER PHARMS INC be worth today?
If you invested $1,000 in CIPHER PHARMS INC (CPHRF) 1 years ago on 2025-10-29, your investment would be worth $934 as of 2026-10-28, a -6.6% price return without dividends, growing at a compounded rate of -6.6% per year (CAGR).
Has CIPHER PHARMS INC outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare CPHRF performance over available time periods.
What is CIPHER PHARMS INC's average annual return?
The compound annual growth rate (CAGR) of CPHRF’s share price over the past 1 years is -6.6%, without dividends. Individual years vary a great deal, and CPHRF’s best recent full year was 2024 (+137.9%) while the worst was 2025 (+10.2%).
For informational and educational purposes only, not investment advice.